http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#head http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#provenance http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://rdf.disgenet.org/resource/gda/DGNf851309a412e1e7e3a1ed5b6f86fa88c http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/2064 http://rdf.disgenet.org/resource/gda/DGNf851309a412e1e7e3a1ed5b6f86fa88c http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0278486 http://rdf.disgenet.org/resource/gda/DGNf851309a412e1e7e3a1ed5b6f86fa88c http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#provenance http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://purl.org/dc/terms/description [The National Surgical Adjuvant Breast and Bowel Project (NSABP) Protocol B-31 is designed to test the advantage of adding Herceptin to the adjuvant chemotherapeutic regimen of doxorubicin and cyclophosphamide followed by paclitaxel (Taxol) in the treatment of stage II breast cancer with HER2 overexpression or gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/12048273 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/dc/terms/created 2017-10-17T13:12:23+02:00 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP346731.RA6HH4O1wkSGT025XI6NHAqgy1NWhpl0Xij1_JHexw4BQ http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0